Task: Answer the multiple-choice question.
Question: Which drug exhibits a -5.048% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. COCCn1c(SCC(=O)Nc2cc(C)on2)nc2c(c1=O)SCC2
b. CCOc1cnc(-c2c(-c3ccccc3Cl)noc2C)o1
Answer: a. COCCn1c(SCC(=O)Nc2cc(C)on2)nc2c(c1=O)SCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCn1c(SCC(=O)Nc2cc(C)on2)nc2c(c1=O)SCC2
COCCn1c(SCC(=O)Nc2cc(C)on2)nc2c(c1=O)SCC2
2-[[3-(2-methoxyethyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]sulfanyl]-N-(5-methyl-1,2-oxazol-3-yl)acetamide